Breaking News Instant updates and real-time market news.

XEC

Cimarex Energy

$70.68

-1.22 (-1.70%)

08:56
03/20/19
03/20
08:56
03/20/19
08:56

Cimarex Energy downgraded to Equalweight from Overweight at Capital One

Capital One downgraded Cimarex Energy to Equal Weight citing gas exposure and an unchanged gas price deck versus an increased oil price deck.

XEC Cimarex Energy
$70.68

-1.22 (-1.70%)

01/29/19
01/29/19
INITIATION

Mizuho initiates seven 'exciting' E&P stocks
Mizuho analyst Paul Sankey expanded his coverage of the E&P, or exploration and production, sector with the initiation of seven U.S.-focused, liquids-weighted E&Ps. Sankey initiated Concho Resources (CXO), Continental Resources (CLR), and Diamondback Energy (FANG) with Buy ratings, and Cimarex Energy Company (XEC), Encana Corporation (ECA), Parsley Energy (PE), and WPX Energy (WPX) with Neutral ratings. The analyst views each of these names as quality operators at varying stages in the transition to "Renaissance E&P." He believes "sustainable cash return growth is the key to making E&Ps competitive, not just relative to their history, but to the broader market," and sees his three Buy-rated names as the furthest along this process.
02/08/19
SUSQ
02/08/19
UPGRADE
SUSQ
Positive
Cimarex Energy upgraded to Positive from Neutral at Susquehanna
02/08/19
SUSQ
02/08/19
UPGRADE
Target $88
SUSQ
Positive
Cimarex Energy upgraded to Positive, price target raised to $88 at Susquehanna
As reported previously, Susquehanna analyst Biju Perincheril upgraded Cimarex Energy to Positive from Neutral. The analyst believes its capital efficiency is set to improve as an extended period of Permian spacing tests, which negatively impacted well productivity, is largely behind the company. This, coupled with more oil-well growth from REN assets, provides a visible path for free-cash-flow generations, said Perincheril, who raised his price target to $88 from $74 on Cimarex shares.
03/12/19
EVER
03/12/19
INITIATION
EVER
In Line
Cimarex Energy resumed with an In Line at Evercore ISI
Evercore ISI analyst Stephen Richardson resumed coverage on Cimarex Energy with an In Line saying margins and growth lag Permian peers and sees better risk/reward elsewhere.

TODAY'S FREE FLY STORIES

OSTK

Overstock.com

$8.29

-0.03 (-0.36%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:41
11/18/19
11/18
14:41
11/18/19
14:41
Hot Stocks
GlobalSCAPE announces $3.35 per share special cash dividend, $5M buyback program »

GlobalSCAPE announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$162.37

5.115 (3.25%)

, NTDOY

Nintendo

$0.00

(0.00%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Periodicals
Roku rolls out fix after new 'Pokemon' games cause crashing problems, Verge says »

Roku (ROKU) confirmed…

ROKU

Roku

$162.37

5.115 (3.25%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FB

Facebook

$197.78

2.71 (1.39%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Hot Stocks
Facebook's Oculus Link launches beta to play PC Rift games wired to Quest »

Oculus said in-part in an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

14:28
11/18/19
11/18
14:28
11/18/19
14:28
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

GSB

GlobalSCAPE

$10.13

0.08 (0.80%)

14:26
11/18/19
11/18
14:26
11/18/19
14:26
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$67.76

-0.63 (-0.92%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Options
Cerner call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRHC

Tabula Rasa HealthCare

$41.26

-0.83 (-1.97%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Conference/Events
Tabula Rasa HealthCare participates in a conference call with Benchmark »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

DNA

Bought by RHHBY

$0.00

(0.00%)

14:23
11/18/19
11/18
14:23
11/18/19
14:23
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry webcast »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:18
11/18/19
11/18
14:18
11/18/19
14:18
Recommendations
MorphoSys analyst commentary  »

MorphoSys B-MIND futility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/18/19
11/18
14:17
11/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/18/19
11/18
14:16
11/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:14
11/18/19
11/18
14:14
11/18/19
14:14
Hot Stocks
MorphoSys says tafasitamab B-MIND study successfully passed futility analysis »

Earlier, MorphoSys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

DISCA

Discovery

$30.74

1.03 (3.47%)

14:03
11/18/19
11/18
14:03
11/18/19
14:03
Hot Stocks
Discovery rises after Malone buys $75M worth of stock »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$196.73

1.66 (0.85%)

14:01
11/18/19
11/18
14:01
11/18/19
14:01
Options
Call volume jumps in Facebook as shares and implied volatility lift »

Call volume jumps in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ABMD

Abiomed

$190.75

-32.48 (-14.55%)

13:54
11/18/19
11/18
13:54
11/18/19
13:54
Hot Stocks
Abiomed falls after studies question Impella heart device at AHA 2019 meeting »

In a story out over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNI

McClatchy

$0.56

0.0846 (17.63%)

13:53
11/18/19
11/18
13:53
11/18/19
13:53
Hot Stocks
Bluestone Financial raises stake in McClatchy to 11.85% »

Bluestone Financial holds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSII

Heidrick & Struggles

$29.39

-0.04 (-0.14%)

13:50
11/18/19
11/18
13:50
11/18/19
13:50
Initiation
Heidrick & Struggles initiated  »

Heidrick & Struggles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

13:50
11/18/19
11/18
13:50
11/18/19
13:50
General news
Fed's Mester said she would have preferred to have kept rates steady »

Fed's Mester said…

CL

Colgate-Palmolive

$67.08

0.71 (1.07%)

13:45
11/18/19
11/18
13:45
11/18/19
13:45
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRTX

Karuna Therapeutics

$73.20

55.94 (324.10%)

13:43
11/18/19
11/18
13:43
11/18/19
13:43
Recommendations
Karuna Therapeutics analyst commentary  »

Karuna Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

STNE

StoneCo

$37.17

-0.73 (-1.93%)

13:35
11/18/19
11/18
13:35
11/18/19
13:35
Options
StoneCo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

13:35
11/18/19
11/18
13:35
11/18/19
13:35
General news
Treasury Action: yields remain modestly lower on the day »

Treasury Action: yields…

I

Intelsat

$11.26

-2.14 (-15.97%)

13:29
11/18/19
11/18
13:29
11/18/19
13:29
Hot Stocks
CBA responds to announcement by FCC Chair regarding C-band spectrum proceeding »

The C-Band Alliance, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ARWR

Arrowhead

$48.38

0.95 (2.00%)

13:27
11/18/19
11/18
13:27
11/18/19
13:27
Recommendations
Arrowhead analyst commentary  »

Arrowhead data validates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.